Meningogenic leukemia for children: 12 mg/m2 or 15 mg whichever is less (about 0.4 - 0.5 mg/kg) intrathecal once or twice weekly.
Acute lymphoblastic leukemia: 15 to 30 mg/m2 once or twice weekly intramuscularly. Alternately, 2.5 mg/kg IV every 14 days.
Choriocarcinoma: 15 to 30 mg daily intramuscularly for 5 days at intervals of 1 to 2 weeks for 3 to 5 courses. Alternately, 0.25 to 1 mg/kg up to max of 60 mg IM every 48 hours for 4 doses followed by folinic acid rescue and repeated at intervals of 7 days.
Mycosis fungoides: 50 mg weekly as a single dose IM.
Osteogenic sarcoma: 12-15 g/m2 IV infusion followed by folinic acid.
Severe psoriasis: 10-25 mg orally, once weekly, is recommended, however, intravenously or intramuscularly is administered. Dosage should be adjusted according to the patient's response and hematological toxicity.
Administration: Small amount administration (IV or IM).
Large amount administration (Rapid IV (bolus injection) or infusion).
Intrathecal or intraarterial administration.
It is administered through tube for infusion over 2 - 3 minutes. In administration of over 100 mg, IV infusion should be done within 24 hours (In initial administration, bolus administration). Dosage over 70 mg/m2 (2.3 mg/kg) should be administered concomitantly with leucovorin rescue therapy, or serum methotrexate level of 24 - 48 hours after administration should be observed.
Methotrexate should be used alone or concomitantly with radiotherapy, surgical therapy.
Determination of dosage should be considered.
Other Services
Country
Account